UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer

Oncotarget, 2015-09, Vol.6 (27), p.23548-23560

2015

Volltextzugriff (PDF)

Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface

The Journal of biological chemistry, 2008-02, Vol.283 (5), p.2822-2834

2008

Volltextzugriff (PDF)

Sarcoma regimens for gynecologic carcinosarcoma: Is there a benefit? (186)

Gynecologic oncology, 2022-08, Vol.166, p.S107

2022

Volltextzugriff (PDF)

Abstract IA06: Stromal regulation of metastasis

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.IA06-IA06

2018

Volltextzugriff (PDF)

Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer

Gynecologic oncology, 2021-08, Vol.162, p.S210-S210

2021

Volltextzugriff (PDF)

Abstract B036: Spatial transcriptomics reveals stepwise biomolecular changes in ovarian cancer tumor microenvironments

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.B036-B036

2024

Volltextzugriff (PDF)

Abstract B053: Lipid metabolism and lipidomics of ovarian clear cell carcinoma: a comprehensive analysis

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.B053-B053

2024

Volltextzugriff (PDF)

Abstract 48: Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.48-48

2012

Volltextzugriff (PDF)

High-depth multi-omics analysis defines the transition of borderline, micropapillary and low-grade serous cancers (2310)

Gynecologic oncology, 2023-09, Vol.176, p.S321-S322

2023

Volltextzugriff (PDF)

Abstract 3062: Metformin inhibits TGFβ-induced stromal ECM remodeling to impede invasion in ovarian cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3062-3062

2017

Volltextzugriff (PDF)

Abstract 3655: Exploring the role of FasL in the ovarian cancer tumor microenvironment

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3655-3655

2023

Volltextzugriff (PDF)

The ratio of toxic-to-nontoxic microRNAs predicts platinum sensitivity in ovarian cancer

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (15), p.3985-4000

2021

Volltextzugriff (PDF)

Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas

Gynecologic oncology, 2022-01, Vol.164 (1), p.32-32

2022

Volltextzugriff (PDF)

Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer

Clinical cancer research, 2016-01, Vol.22 (2_Supplement), p.A68-A68

2016

Volltextzugriff (PDF)

Abstract A28: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A28-A28

2018

Volltextzugriff (PDF)

Reversal of Chemoresistance in Ovarian Cancer by Co‐Delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform

The FASEB journal, 2015-04, Vol.29 (S1)

2015

Volltextzugriff (PDF)

Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6068-6068

2023

Volltextzugriff (PDF)

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

Gynecologic oncology, 2011-05, Vol.121 (2), p.273-279

2011

Volltextzugriff (PDF)

Abstract IA30: Metabolic symbiosis: The contribution of adipocytes to visceral metastasis

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3_Supplement), p.IA30-IA30

2013

Volltextzugriff (PDF)

Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_2), p.A107-A107

2024

Volltextzugriff (PDF)

Deconstructing tumor heterogeneity: the stromal perspective

Oncotarget, 2020-10, Vol.11 (40), p.3621-3632

2020

Volltextzugriff (PDF)

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-097-NT-097

2019

Volltextzugriff (PDF)

Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A15-A15

2018

Volltextzugriff (PDF)

Abstract 5474: Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5474-5474

2018

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(102)
Bücher
(2)

Sprache

Englisch
(102)
Japanisch
(4)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer

Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and β1-Integrin on the Cell Surface

Sarcoma regimens for gynecologic carcinosarcoma: Is there a benefit? (186)

Abstract IA06: Stromal regulation of metastasis

Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer

Abstract B036: Spatial transcriptomics reveals stepwise biomolecular changes in ovarian cancer tumor microenvironments

Abstract B053: Lipid metabolism and lipidomics of ovarian clear cell carcinoma: a comprehensive analysis

Abstract 48: Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment

High-depth multi-omics analysis defines the transition of borderline, micropapillary and low-grade serous cancers (2310)

Abstract 3062: Metformin inhibits TGFβ-induced stromal ECM remodeling to impede invasion in ovarian cancer

Abstract 3655: Exploring the role of FasL in the ovarian cancer tumor microenvironment

The ratio of toxic-to-nontoxic microRNAs predicts platinum sensitivity in ovarian cancer

Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas

Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer

Abstract A28: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment

Reversal of Chemoresistance in Ovarian Cancer by Co‐Delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform

Abstract 6068: Methylomic, transcriptomic and immune profiles of high grade serous ovarian cancer among Black and non-Hispanic White women

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

Abstract IA30: Metabolic symbiosis: The contribution of adipocytes to visceral metastasis

Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

Deconstructing tumor heterogeneity: the stromal perspective

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis

Abstract 5474: Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin

Aktive Filter

Suchergebnisse filtern